Glycogen storage disease type 2 (Pompe disease)
ABGC-listedListed on the ABGC Self-Study GuideLog in to starLast updated 2mo ago
Log in to add personal notes on this page.
An infant with severe hypotonia has cardiomegaly with short PR interval. CK is elevated. Acid alpha-glucosidase activity is deficient.
AR; GAA (acid alpha-glucosidase/acid maltase)
- Lysosomal storage disorder
- Infantile: Cardiomegaly (massive), hypotonia, respiratory failure, death in first year
- Late-onset: Progressive myopathy, respiratory weakness
- CK elevated
- ECG: Short PR, LVH
- On RUSP
- On RUSP: flagged by low acid alpha-glucosidase (GAA) activity on newborn screening
- Deficient GAA enzyme activity (dried blood spot, then confirmatory leukocyte/fibroblast assay) is diagnostic
- GAA molecular testing confirms and predicts phenotype; CRIM (cross-reactive immunologic material) status guides immune management before enzyme replacement
- Enzyme replacement therapy (alglucosidase alfa)
PomPe trashes the PumP: the heart (pump) is prominently affected with massive cardiomegaly. Also a lysosomal storage disorder.
"Pumped for MLH": glycogen accumulates in Muscle (hypotonia), Liver (hepatomegaly), and Heart (hypertrophic cardiomyopathy). Also accumulates in the tongue (macroglossia).
Type II GSD x 2 = alpha-1,4: the enzyme (acid maltase/alpha-1,4-glucosidase) cleaves alpha-1,4 linkages. Normal blood glucose (unlike von Gierke and Cori), because the lysosomal pathway is not essential for blood glucose maintenance.